Login to Your Account



R&D tax incentive unscathed: Aussie firms laud federal budget

By Tamra Sami
Staff Writer

Wednesday, May 10, 2017

PERTH, Australia – Australia's biopharma and medical device industries breathed a collective sigh of relief that the Australian Government's 2017 budget announced May 9 left the much-loved R&D tax incentive untouched.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription